1. Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice
   Gherardo Mazziotti et al, 2020, Endocrine CrossRef
2. Potential prognostic value of miR-132 and miR-212 expression in mCRPC patients
   Mariano Pontico et al, 2021, Archivio Italiano di Urologia e Andrologia CrossRef
3. Inhibition of castration-resistant prostate cancer growth by genistein through suppression of AKR1C3
   Xiaoping Yu et al, 2023, Food & Nutrition Research CrossRef
4. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature
   Viviana Frantellizzi et al, 2020, Current Medical Imaging Formerly Current Medical Imaging Reviews CrossRef
5. Prognostic Value of 18F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
   Luca Filippi et al, 2020, Biomedicines CrossRef
6. Evaluation of the 223Ra-dichloride biodistribution models for the assessment of the doses from internal exposure
   Aleksandr V. Vodovatov et al, 2020, Pharmacy Formulas CrossRef
7. Еfficiacy and safety of radium-223 in the treatment of metastatic castration-resistant prostate cancer
   I. G. Rusakov et al, 2020, Meditsinskiy sovet = Medical Council CrossRef
8. A Case of Success: Complete Response to Radium-223 in Metastatic Castration-Resistant Prostate Cancer
   Inês Soares de Pinho et al, 2024, Cureus CrossRef
9. A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223
   Viviana Frantellizzi et al, 2021, Aging Clinical and Experimental Research CrossRef